	Atypical Cutaneous Manifestation Leading to the Diagnosis of Chronic Lymphocytic Leukemia. Cureus Memon M. PMID: 42261453 [PubMed]
	Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE study. Hemasphere Cheah CY, Blombery P, Johnston A, Wight J, Lewis KL, Bennett R, Xie J, Vlachos S, Hunter SM, Gonzales J, Binks S, Seymour JF. PMID: 42261375 [PubMed]
	Exosomes liquid biopsy in Lymphoma precision medicine: applications and challenges. Cancer Cell Int Liu J, Peng Y, Zhang Y, Xiang H, Lu Y, Chen S, Lin C, Jiang T, Tang X, Liu Y, Yang Z. PMID: 42260559 [PubMed - as supplied by publisher]
	Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case. Ann Clin Lab Sci Yang R, Ye MT, Medeiros CG, Ye F, You MJ. PMID: 42259539 [PubMed - in process]
	Longitudinal Changes in Body Weight and Body Mass Index in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Observational Study. Oncology Alshurafa A, Abdulgayoom M, Ghasoub R, M Mohammed W, R Wafi J, Al Ali F, Yassin MA. PMID: 42258604 [PubMed - as supplied by publisher]
	Anti-CD123 monoclonal antibodies as therapeutic agents for acute myeloid leukemia: a systematic review. Expert Rev Hematol Vito VM, Boff VA, Demarchi IG, de Moraes ACR. PMID: 42257293 [PubMed - as supplied by publisher]
	Diagnostic Significance of Circulating EBV-miR-BHRF1-3 and EBV-miR-BART2-5p in Lymphoma A Case-Control Study. Pak J Med Sci Kara A, Kizilkaya M, Balkan E, Erdem F, Turkez H. PMID: 42257093 [PubMed]
	Primary Extramedullary Acute Promyelocytic Leukemia Presenting as Cauda Equina Syndrome: A Rare Case Report and Diagnostic Challenge. Clin Case Rep Ali A, Ringor M, Khalid A, Garcia D, Konchada R, Ratnasabapathy R, Chae Y, Melikyan A, Yaghmour G. PMID: 42256917 [PubMed]
	Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study. Hemasphere Polverelli N, Chiappella A, Carniti C, Zinzani P, Musso M, Tisi MC, Ciceri F, Cutini I, Santoro A, Chiusolo P, Barbui AM, Farina M, Donzelli L, Brunello L, Martino M, Krampera M, Castellino A, Grillo G, Botto B, Olivieri J, Clerico M, Musto P, Olivieri A, Bianchessi A, Defrancesco I, Losi G, Zerbi C, Martini G, Roncoroni E, Gotti M, Benevento MG, Taurino A, Fedina A, Corradini P, Arcaini L. PMID: 42256547 [PubMed]
	Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial. Hemasphere Maher N, Moia R, Almasri M, Cividini L, Genuardi E, Cosentino C, Soscia R, Assanto GM, Tavarozzi R, Vegliante MC, Lorenzi L, Andorno A, Arcaini L, Ragaini S, Puccini B, Patti C, Santoro A, Margiotta-Casaluci G, Zilioli VR, Zanni M, Ronconi S, Di Raimondo F, Arcari A, Califano C, Castellino C, Conconi A, Perrone T, Mannina D, Plenteda C, Alesiani F, Rossi FG, Carella AM, Marcheselli L, Galimberti S, Ciavarella S, Bomben R, Del Giudice I, Ladetto M, Gaidano G, Luminari S, Ferrero S. PMID: 42256545 [PubMed]
	Access to diagnosis using liquid biopsy (ADLiB): Identifying lymphoma in a tuberculosis-endemic setting. Hemasphere Antel K, Xiong N, Merrill M, Chen T, McGrath L, Droessler C, van der Schyff M, Wu MX, Cheddie D, Slome C, McBride L, Day J, Mohamed Z, Fakie N, Mbatani N, Shultz C, Meintjes G, Tyekucheva S, Cohen EF, Tolstorukov MY, Verburgh E, Murakami MA. PMID: 42255950 [PubMed]
	Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single-Cell RNA Sequencing Validation. Int J Genomics Xia T, Wen R, Wu G, Hong Y, Luo D. PMID: 42255490 [PubMed]
	Existing and emerging strategies for fertility preservation in female patients with leukemia. Front Endocrinol (Lausanne) Abazarikia A, Purkayastha A, So W, Rasekhi M, Kim SY. PMID: 42255431 [PubMed - indexed for MEDLINE]
	A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18). Blood Neoplasia Assouline S, Prica A, Villa D, Kridel R, Johnson N, Kukreti V, Shamy A, Kaedbey R, Gerrie A, Savage K, Kelly J, Shepherd LE, Hay AE, Scott DW, Crump M, Chen BE, Kuruvilla J. PMID: 42255257 [PubMed]
	A systematic evaluation of double-expressor lymphoma: prognostic impact, determinants of outcome, and comparative efficacy and safety of novel therapies. Front Oncol Guan H, Liu Z, Gao C, Wang W, Liu K, Zhao X. PMID: 42255243 [PubMed]
	Cost-effectiveness analysis of ibrutinib plus venetoclax for relapsed or refractory mantle cell lymphoma in China and the United States. Front Public Health He J, Liu X, Yang Q. PMID: 42254648 [PubMed - in process]
	Aberrant polyploidization pathways in megakaryocytes as therapeutic targets in leukemia. Ann Med Surg (Lond) Obeagu EI. PMID: 42254093 [PubMed]
	Weekly Cladribine Followed by Rituximab for the Treatment of Hairy Cell Leukemia. EJHaem Turner JA, Santos J, Pizzuti V, Paton E, Robinson WA. PMID: 42253635 [PubMed]
	High-risk cytogenetic abnormalities impact the cytological and clinical behavior of core binding factor acute myeloid leukemia: a case-control study. BMC Cancer El Achkar H, Bazarbachi A, Chakhachiro Z, Mahfouz R, Assaf N. PMID: 42252425 [PubMed - as supplied by publisher]
	Anchoring on Alcohol: Delayed Diagnosis of Splenic Lymphoma. Am J Med Awan M, Chang A, Suneja M. PMID: 42252010 [PubMed - as supplied by publisher]

Articles 1 - 20 / 168145

Page 1 of 8408



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy